Accent Microcell Limited (NSE:ACCENTMIC)

-5.34% (1Y)

Market Cap	5.86B
Revenue (ttm)	2.65B
Net Income (ttm)	330.63M
Shares Out	21.04M
EPS (ttm)	15.71
PE Ratio	17.72
Forward PE	n/a
Dividend	1.00 (0.36%)
Ex-Dividend Date	n/a

Volume	58,500
Average Volume	76,725
Open	280.00
Previous Close	278.35
Day's Range	277.15 - 282.30
52-Week Range	180.00 - 306.65
Beta	n/a
RSI	67.44
Earnings Date	Jul 17, 2025

About Accent Microcell

Accent Microcell Limited manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally. The company offers microcrystalline cellulose, cellulose powder, microcrystalline cellulose spheres, silicified microcrystalline cellulose, crosscarmellose sodium, magnesium stearate, and microcrystalline cellulose with carboxy methyl cellulose. It also provides supply chain management, on-time material delivery, customer assistance, and commitment services. The company sells its products under the...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 174
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACCENTMIC

Financial Performance

In 2024, Accent Microcell's revenue was 2.65 billion, an increase of 7.72% compared to the previous year's 2.46 billion. Earnings were 330.63 million, an increase of 9.60%.